Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Sergio López-Buenrostro"'
Autor:
Myrna Luna-Gutiérrez, Rodrigo Hernández-Ramírez, Airam Soto-Abundiz, Osvaldo García-Pérez, Alejandra Ancira-Cortez, Sergio López-Buenrostro, Brenda Gibbens-Bandala, Irma Soldevilla-Gallardo, Nancy Lara-Almazán, Melissa Rojas-Pérez, Blanca Ocampo-García, Erika Azorín-Vega, Clara Santos-Cuevas, Guillermina Ferro-Flores
Publikováno v:
Pharmaceutics, Vol 15, Iss 7, p 1988 (2023)
177Lu-iPSMA is a novel radioligand developed at ININ-Mexico with a high affinity for the PSMA protein heavily expressed in cancer cells of approximately 95% of patients with metastatic castration-resistant prostate cancer (mCRPC). 177Lu-DOTATOC is a
Externí odkaz:
https://doaj.org/article/5d0dae5e07b64950ba7b769e4bd92c95
Autor:
Francisco Osvaldo, García-Pérez, Jenny, Davanzo, Sergio, López-Buenrostro, Clara, Santos-Cuevas, Guillermina, Ferro-Flores, Miguel A, Jímenez-Ríos, Anna, Scavuzzo, Zael, Santana-Ríos, Sevastián, Medina-Ornelas
Publikováno v:
American journal of nuclear medicine and molecular imaging. 8(5)
Positron emission tomography (PET) with prostate-specific membrane antigen (PSMA) has found widespread use for the diagnosis of biochemical recurrence of prostate cancer (PCa). Unfortunately, PET/CT is not as widely available; thus a PSMA-targeting c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0108c3084e76f8ce326a8c5ae99fa86a
https://pubmed.ncbi.nlm.nih.gov/30510850
https://pubmed.ncbi.nlm.nih.gov/30510850